Alembic Pharmaceuticals Incorporates New Thai Subsidiary To Expand Presence In South-East Asian MarketsA

AlembicPharmaceuticals has incorporated a subsidiary in Thailand named Alembic Pharmaceuticals (Thailand) Co., Ltd to explore new business opportunities within the geography, specifically to promote, sell, and distribute pharmaceutical products of the parent company, the company said in a regulatory filing. 

According to the filing, the subsidiary features a registered share capital of 3,000,000 baht. This capital allocation is divided into 300,000 shares, each maintaining a valuation of 10 baht. The parent Alembic Pharmaceuticals acquired a 99.99% shareholding in the new Thai entity. 

The filing indicated that, given its status as a newly incorporated entity, Alembic Pharmaceuticals (Thailand), reports a nil turnover and has not yet commenced business operations.